Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma

被引：16
|
作者：
Takagi, K
Yoshida, A
Iwasaki, H
Inoue, H
Ueda, T
机构：
[1] Univ Fukui, Fac Med Sci, Dept Internal Med 1, Fukui 9101193, Japan
[2] Fukui Natl Hosp, Div Internal Med, Tsuruga, Japan
来源：
ANNALS OF HEMATOLOGY | 2005年 / 84卷 / 08期
关键词：
Follicular Lymphoma; Immune Thrombocytopenic Purpura; Autoimmune Hemolytic Anemia; Mixed Cryoglobulinemia; Cold Agglutinin Disease;
D O I：
10.1007/s00277-005-1050-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：548 / 550
页数：3
相关论文
共 50 条
  • [1] Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
    Kazutaka Takagi
    Akira Yoshida
    Hiromichi Iwasaki
    Hitoshi Inoue
    Takanori Ueda
    [J]. Annals of Hematology, 2005, 84 : 548 - 550
  • [2] Anti-CD20 (rituximab) in follicular lymphoma
    McLaughlin, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S51 - S51
  • [3] Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?
    Armitage, James O.
    Longo, Dan L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1389 - 1390
  • [4] Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    Morrison, LH
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 817 - 819
  • [5] Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20+ follicular lymphoma-associated paraneoplastic pemphigus
    Borradori, L
    Lombardi, T
    Samson, J
    Girardet, C
    Saurat, JH
    Hügli, A
    [J]. ARCHIVES OF DERMATOLOGY, 2001, 137 (03) : 269 - 272
  • [6] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    [J]. ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [7] Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
    Piro, LD
    White, CA
    Grillo-López, AJ
    Janakiraman, N
    Saven, A
    Beck, TM
    Varns, C
    Shuey, S
    Czuczman, M
    Lynch, JW
    Kolitz, JE
    Jain, V
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (06) : 655 - 661
  • [8] Anti-CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis
    Korhonen, Riku
    Moilanen, Eeva
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (01) : 13 - 21
  • [9] Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
    Arin, MJ
    Engert, A
    Krieg, T
    Hunzelmann, N
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) : 620 - 625
  • [10] Combination monoclonal antibody therapy for lymphoma: Treatment with epratuzumab (anti-CD22) and rituximab (anti-CD20) is well tolerated.
    Leonard, JP
    Coleman, M
    Matthews, JC
    Fiore, JM
    Dosik, A
    Kapushoc, H
    Kin, E
    Cesano, A
    Wegener, WA
    Goldenberg, DM
    [J]. BLOOD, 2001, 98 (11) : 844A - 844A
12345